Harvard Bioscience Inc. (HBIO) Posts Q1 EPS of $0.07,Shy Y/Y
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $8.90 +1.14%
Revenue Growth %: +6.1%
Financial Fact:
Amortization of intangible assets: 729K
Today's EPS Names:
OPY, BNCC, ZVOI, More
Revenue Growth %: +6.1%
Financial Fact:
Amortization of intangible assets: 729K
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Harvard Bioscience Inc. (Nasdaq: HBIO) reported Q1 EPS of $0.07, versus $0.09 last year. Revenue for the quarter came in at $26.3 million, versus $26.3 million last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Verra Mobility (VRRM) Tops Q3 EPS by 10c ; Offers Guidance
- Arbor Realty Trust (ABR) Misses Q3 EPS by 8c
- nVent Electric (NVT) Tops Q3 EPS by 13c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
